Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Vomiting 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Prostate Cancer Prevention 1Postoperative Nausea and Vomiting 1Multiple Endocrine Neoplasia Type 1 1Healthy Volunteers 1Dermatitis, Contact 1Colorectal Neoplasms 1Breast Neoplasms 1Atypical Squamous Cells of the Cervix 1

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Gelatin × Clear all
NCT02234466 2014-09-09

Preoperative Oral Dexamethasone to Improve Recovery After Surgery

University of Manitoba

Phase 2 Unknown
80 enrolled
Breast

Breast Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡